Toxicity of parenteral iron dextran therapy

Kidney International, Supplement

Volumn 55, Issue 69, 1999, Pages

  Burns, David L ^a,b   Pomposelli, James J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

Anemia; Blood transfusion; Hemodialysis; Iron deficiency; Malnutrition

Indexed keywords

IRON DEXTRAN; IRON;

ANAPHYLAXIS; AUTOIMMUNE DISEASE; BRONCHOSPASM; FEVER; HEMODIALYSIS; HUMAN; HYPOTENSION; INFECTION; INJECTION PAIN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY ANEMIA; IRON OVERLOAD; KIDNEY FAILURE; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MYALGIA; PRIORITY JOURNAL; REVIEW; RIGOR; SEIZURE; SKIN DEFECT; INFUSION; METABOLISM; MUSCLE DISEASE;

ANEMIA, IRON-DEFICIENCY; AUTOIMMUNE DISEASES; HUMANS; INFECTION; INFUSIONS, PARENTERAL; IRON; IRON OVERLOAD; IRON-DEXTRAN COMPLEX; MUSCULAR DISEASES;

EID: 0032962843     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.055suppl.69119.x     Document Type: Review

References (34)

1. FISHBANE S, UNGUREANU V, MAESAKA J, KAUPKE C, LIM V, WISH J: The safety of intravenous iron dextran in hemodialysis patients. Am J Kidney Dis 28:529-534, 1996
2. BURNS DL, MASCIOLI EA, BISTRIAN B: Parenteral iron dextran: A review. Nutrition 11:163-168, 1995
3. BURNS DL, MASCIOLI EA, BISTRIAN B: Effect of iron-supplemented total parenteral nutrition in patients with iron deficiency anemia. Nutrition 12:411-415, 1996
4. HAMSTRA RD, BLOCK MH, SCHOCKET AL: Intravenous iron dextran in clinical medicine. JAMA 243:1726-1731, 1980
5. WALLERSTEIN RO: Intravenous iron-dextran complex. Blood 32:690-695, 1968
6. AUERBACH M, WITT D, TOLER W, FIERSTEIN M, LERNER RG, BALLARD H: Clinical use of the total dose intravenous infusion of iron dextran. J Lab Clin Med 111:566-570, 1988
7. NOVEY HS, PAHL MP, HAYDIK I, VAZIRI ND: Immunologic studies of anaphylaxis to iron dextran in patients on renal dialysis. Ann Allergy 72:224-228, 1994
8. MONAGHAN MS, GLASCO G, ST. JOHN G, BRADSHER RW, OLSEN KM: Safe administration of iron dextran to a patient who reacted to the test dose. South Med J 87:1010-1012, 1994
9. PORTER KA, BLACKBURN GL, BISTRIAN B: Safety of iron dextran in total parenteral nutrition: A case study. J Am Coll Nutr 7:107-110, 1988
10. BLAKE DR, LUNEC J, AHERN M, RING EF, BRADFIELD J, GUTTERIDGE IM: Effect of intravenous iron dextran on rheumatoid synovitis. Ann Rheum Dis 44:183-188, 1985
11. OH VMS: Iron dextran and systemic lupus erythematosis. BMJ 305:1000, 1992
12. REDDY PS, LEWIS M: The adverse effect of intravenous iron-dextran in rheumatoid arthritis. Arthritis Rheum 12:454-457, 1969
13. RON D: The reticuloendothelial system and rheumatoid arthritis. (letter) Lancet 2:901, 1979
14. FOULKES WD, SEWRY C, CALAM J, HODGSON HJF: Rhabdomyolysis after intramuscular iron-dextran in malabsorption. (abstract) Ann Rheum Dis 50:184-186, 1991
15. GREENBERG G: Sarcoma after intramuscular iron injection. BMJ 3:1508-1509, 1976
16. EDWARDS CQ: Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 318:1355-1359, 1988
17. FLEMING LW, HOPWOOD D, SHEPHARD AN, STEWART WK: Hepatic iron in dialysed patients given intravenous iron dextran. J Clin Pathol 43:119-124, 1990
18. MURRAY JA, SLATER DN, PARSONS MA, FOX M, SMITH S, PLATTS MM: Splenic siderosis and parenteral iron dextran in maintenance haemodialysis patients. J Clin Pathol 37:59-64, 1984
19. ALI M, FAYEMI AO, RIGOLOSI R, FRASCINO J, MARSDEN T, MALCOLM D: Hemosiderosis in hemodialysis patients. JAMA 244:343-345, 1980
20. CASEY LC, BALK RA, BONE RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119:771-777, 1993
21. WEINBERG ED: Nutritional immunity. JAMA 231:39-41, 1975
22. WEINBERG ED: Iron and infection. Microbiol Rev 42:45-66, 1978
23. BEISEL WR: Trace elements in infectious processes. Med Clin N Am 60:831-849, 1976
24. BOTHE A, BENOTTI P, BISTRIAN BR, BLACKBURN GL: Use of iron with total parenteral nutrition. (letter) N Engl J Med 239:1153, 1975
25. MCFARLANE H, REDDY S, ADCOCK KJ, ADESHINA H, COOKE AR, AKENE J: Immunity. transferrin and survival in kwashiorkor. BMJ 4:268-270, 1970
26. MELBY K, SLORDAHL S, GUTTEBERG TJ, NORDBO SA: Septicaemia due to Yersinia enterocolitica after oral overdoses of iron. BMJ 285:467-485, 1982
27. MURRAY MJ, MURRAY AB, MURRAY MB, MURRAY CJ: The adverse effect of iron repletion on the course of certain infections. BMJ 2:1113-1115, 1978
28. SEIFERT A, VON HERRATH D, SCHAEFER K: Iron overload, but not treatment with desferrioxamine favours the development of septicemia in patients on maintenance hemodialysis. Q J Med 248:1015-1024, 1987
29. TIELEMANS C, LENCLUD C: Respective role of haemosiderosis and desferrioxamine therapy in the risk from infection of hemodialysed patients. Q J Med 255:573-574, 1988
30. KUVIBIDILA S, DARDENNE M, SAVINO W, LEPAULT F: Influence of iron-deficiency anemia on selected thymus functions in mice: Thymulin biological activity. T-cell subsets, and thymocyte population. Am J Clin Nutr 51:228-232, 1990
31. CHANDRA RK: Impaired immunocompetence associated with iron deficiency. J Pediatr 86:899-902, 1975
32. VAN ASBECK BS, VERBRUGH HA, VAN OOST BA, MARX JJ, IMHOF HW, VERHOFF J: Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload. BMJ 284:542-544, 1982
33. FLAMENT J, GOLDMAN M, WATERLOT Y, DUPONT E, WYBRAN J, VANHERWEGHEM JL: Impairment of phagocyte oxidative metabolism in hemodialyzed patients with iron overload. Clin Nephrol 25:227-230, 1986
34. WATERLOT Y, CANTINIEAUX B, HARIGA-MULLER C, MAERTELAERE-LAURENT E, VANHERWEGHEM JL, FONDU P: Impaired phagocytic activity of neutrophils in patients receiving hemodialysis: The critical role of iron overload. BMJ 291:501-504, 1985